S-2367 Placebo

DRUG2 trials

Sponsors

Shionogi

Conditions

Obesity

Phase 2

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

CompletedNCT00747929

ShionogiObesity

Start: 2007-06-30End: 2009-01-31Updated: 2018-05-11

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

CompletedNCT00748605

ShionogiObesity

Start: 2007-06-30End: 2009-01-31Updated: 2018-05-11